FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Francesc Jané

Research Profile

Living Beings

Chemicals & Drugs

Physiology

Procedures

Activities & Behaviors

Concepts & Ideas

Anatomy

Substantia Nigra

Co-author Network

Publications

TOP 3
M J Barbanoj; Rosa Antonijoan; Jordi Riba; M Valle; Romero Sergio; Francesc Jané
Quantifying drug-drug interactions in pharmaco-EEG.
Manel J Barbanoj; Consuelo García-Gea; Rosa Antonijoan; Iñaki Izquierdo; Ester Donado; Iñaki Pérez; Anna Solans; Francesc Jané
Evaluation of the cognitive, psychomotor and pharmacokinetic profiles of rupatadine, hydroxyzine and cetirizine, in combination with alcohol, in healthy volunteers.
Manel J Barbanoj; Rosa Antonijoan; Consuelo García-Gea; Montserrat Puntes; Ignasi Gich; Francesc Jané
Eberconazole cream: topical and general tolerability, sensitisation potential, and systemic availability.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Francesc Jané (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: M J Barbanoj; Rosa Antonijoan; Jordi Riba; M Valle; Romero Sergio; Francesc Jané
Quantifying drug-drug interactions in pharmaco-EEG.
Clinical EEG and neuroscience : official journal of the EEG and Clinical Neuroscience Society (ENCS) 2006;37(2):108-20.
2006: Manel J Barbanoj; Consuelo García-Gea; Rosa Antonijoan; Iñaki Izquierdo; Ester Donado; Iñaki Pérez; Anna Solans; Francesc Jané
Evaluation of the cognitive, psychomotor and pharmacokinetic profiles of rupatadine, hydroxyzine and cetirizine, in combination with alcohol, in healthy volunteers.
Human psychopharmacology 2006;21(1):13-26.
2005: Manel J Barbanoj; Rosa Antonijoan; Consuelo García-Gea; Montserrat Puntes; Ignasi Gich; Francesc Jané
Eberconazole cream: topical and general tolerability, sensitisation potential, and systemic availability.
Methods and findings in experimental and clinical pharmacology 2005;27(4):227-34.
2004: Manel J Barbanoj; Consuelo García-Gea; Adelaida Morte; Iñaki Izquierdo; Iñaki Pérez; Francesc Jané
Central and peripheral evaluation of rupatadine, a new antihistamine/platelet-activating factor antagonist, at different doses in healthy volunteers.
Neuropsychobiology 2004;50(4):311-21.
2004: Jordi Riba; Peter Anderer; Francesc Jané; Bernd Saletu; Manel J Barbanoj
Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography.
Neuropsychobiology 2004;50(1):89-101.
2002: Jordi Riba; Peter Anderer; Adelaida Morte; Gloria Urbano; Francesc Jané; Bernd Saletu; Manel J Barbanoj
Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers.
British journal of clinical pharmacology 2002;53(6):613-28.
2002: Manel J Barbanoj; Jordi Riba; Adelaida Morte; Rosa Antonijoan; Francesc Jané
Basics of PK-PD using QEEG: acute/repetitive administration, interactions. Focus on anxiolytics with different neurochemical mechanisms as examples.
Methods and findings in experimental and clinical pharmacology 2002;24 Suppl C():67-83.
2002: Manel J Barbanoj; José-Luis Lorenzo; Susana Clos; Consuelo García-Gea; Francesc Jané
Proof of safety of drugs: focus on vigilance.
Methods and findings in experimental and clinical pharmacology 2002;24 Suppl C():51-64.
2002: M Valle; Manel J Barbanoj; Francesc Jané
Pharmaco-electroencephalography and pharmacokinetic/pharmacodynamic modeling in basic research: focus on human pharmacology.
Methods and findings in experimental and clinical pharmacology 2002;24 Suppl D():129-37.
2000: Gemma Prat; Patricia Robledo; Antonia Rubio; Manel J Barbanoj; Francesc Jané; Miguel Casas
Effects of sub-chronic combined treatment with pergolide and caffeine on contralateral rotational behavior in unilateral 6-hydroxydopamine-denervated rats.
Brain research 2000;868(2):376-9.
2000: Miguel Casas; Gemma Prat; Patricia Robledo; Manel J Barbanoj; Jaime Kulisevsky; Francesc Jané
Methylxanthines reverse the adipsic and aphagic syndrome induced by bilateral 6-hydroxydopamine lesions of the nigrostriatal pathway in rats.
Pharmacology, biochemistry, and behavior 2000;66(2):257-63.
2000: Miguel Casas; Gemma Prat; Antonia Rubio; Manel J Barbanoj; Francesc Jané
Lack of synergism between caffeine and SKF 38393 on rotational behavior in 6-hydroxydopamine-denervated rats.
European journal of pharmacology 2000;396(2-3):93-9.
1999: Miguel Casas; Gemma Prat; Patricia Robledo; Manel J Barbanoj; Jaime Kulisevsky; Francesc Jané
Repeated co-administration of caffeine and bromocriptine prevents tolerance to the effects of caffeine in the turning behavior animal model.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1999;9(6):515-21.
1999: Manel J Barbanoj; Rosa Antonijoan; Adelaida Morte; J M Grinyó; R Solà; J Vallès; Concepción Peraire; José Antonio Cordero; A Muñoz; Francesc Jané; Rosendo Obach
Pharmacokinetics of the somatostatin analog lanreotide in patients with severe chronic renal insufficiency.
Clinical pharmacology and therapeutics 1999;66(5):485-91.
1999: Miguel Casas; Gemma Prat; Patricia Robledo; Francesc Jané
Rotational behavior in dopamine nigrostriatal denervated rats: effects of a wide range of time intervals between apomorphine administrations.
Pharmacology, biochemistry, and behavior 1999;62(3):481-5.
1999: J Borja; Francesc Jané
Cefepime versus ceftriaxone for empiric treatment of hospitalized patients with community-acquired pneumonia.
Antimicrobial agents and chemotherapy 1999;43(2):436-7.
1999: Miguel Casas; Gemma Prat; Patricia Robledo; Manel J Barbanoj; Jaime Kulisevsky; Francesc Jané
Scopolamine prevents tolerance to the effects of caffeine on rotational behavior in 6-hydroxydopamine-denervated rats.
European journal of pharmacology 1999;366(1):1-11.
1998: Manel J Barbanoj; P Parra; Francesc Jané
Buspirone plasma concentrations.
Clinical pharmacology and therapeutics 1998;64(3):347-8.
1997: E Massana; Manel J Barbanoj; C Moros; Adelaida Morte; Ignasi Gich; Francesc Jané
No sex-related pharmacokinetic and pharmacodynamic differences of captopril.
Pharmacological research : the official journal of the Italian Pharmacological Society 1997;36(1):41-7.
1996: D Sáenz-Campos; M Bayés; E Masana; S Martín; Manel J Barbanoj; Francesc Jané
Sex-related pharmacokinetic and pharmacodynamic variations of lisinopril.
Methods and findings in experimental and clinical pharmacology 1996;18(8):533-8.
1996: Manel J Barbanoj; G Salazar; Adelaida Morte; R M Antonijoan; Ignasi Gich; Francesc Jané
Grounds for the integration of pharmacokinetic-pharmacodynamic data.
Methods and findings in experimental and clinical pharmacology 1996;18 Suppl C():43-5.
1996: G Calvo; R Morros; S Mateu; F Torres; J Torrent; Francesc Jané
Adverse drug reactions in HIV positive hospitalized patients. A one-year drug surveillance program: study design.
Methods and findings in experimental and clinical pharmacology 1996;18 Suppl C():27-8.
1996: M Bayés; Manel J Barbanoj; J Vallès; J Torrent; R Obach; Francesc Jané
A drug interaction study between cicletanine and tolbutamide in healthy volunteers.
European journal of clinical pharmacology 1996;50(5):381-4.
1995: O Azcona; Manel J Barbanoj; J Torrent; Francesc Jané
Evaluation of the central effects of alcohol and caffeine interaction.
British journal of clinical pharmacology 1995;40(4):393-400.
1995: D Sáenz-Campos; M Bayés; S Martin; Manel J Barbanoj; Francesc Jané
Gender related pharmacokinetics of diltiazem in healthy subjects.
International journal of clinical pharmacology and therapeutics 1995;33(7):397-400.
1995: Manel J Barbanoj; R M Antonijoan; Francesc Jané
Buspirone and electroencephalography.
Clinical pharmacology and therapeutics 1995;57(6):699.
1995: Francesc Jané
[Pharmacological treatment of Alzheimer's disease: present situation and perspectives].
Revista de neurologia 1995;23(119):103-7.
1993: C García-Cases; A Duque; J Borja; I Izquierdo; V de la Fuente; J Torrent; Francesc Jané
Evaluation of the methodological quality of clinical trial protocols. A preliminary experience in Spain.
European journal of clinical pharmacology 1993;44(4):401-2.
1992: A Cisteró; M Abadías; R Lleonart; V Lafuente; E Pintó; J Torrent; Francesc Jané
Effect of astemizole on allergic asthma.
Annals of allergy 1992;69(2):123-7.
1992: J Borja; A Duque; Josep Guindo; Francesc Jané
[Magnesium sulfate in the treatment of asthma].
Revista clínica española 1992;191(3):174.
1991: J Ramis; R Mis; J Forn; J Torrent; Eduard Gorina; Francesc Jané
Pharmacokinetics of triflusal and its main metabolite HTB in healthy subjects following a single oral dose.
European journal of drug metabolism and pharmacokinetics 1991;16(4):269-73.
1991: R Lleonart; M Abadías; O Monés; Francesc Jané; A Olivé; A Cisteró
[Hypersensitivity reactions to ethylenediamine].
Revista clínica española 1991;188(9):463-5.
1990: jordi rello; A Roglan; C García-Cases; Francesc Jané; A Net
Effect of continuous arteriovenous hemodialysis on ganciclovir pharmacokinetics.
DICP : the annals of pharmacotherapy 1990;24(5):544-5.
1990: S Ferré; T Guix; J Sallés; Albert Badia; P Parra; Francesc Jané; Mario Herrera-Marschitz; U Ungerstedt; Miguel Casas
Paraxanthine displaces the binding of [3H]SCH 23390 from rat striatal membranes.
European journal of pharmacology 1990;179(3):295-9.
1990: S Ferré; Gemma Prat; T Guix; M Gomá; Francesc Jané; Miguel Casas
T-maze performance in rats following chronic neuroleptic treatment.
Pharmacology, biochemistry, and behavior 1990;35(2):481-4.
1990: R M Antonijoan; Manel J Barbanoj; J Torrent; Francesc Jané
Evaluation of psychotropic drug consumption related to psychological distress in the elderly: hospitalized vs. nonhospitalized.
Neuropsychobiology 1990;23(1):25-30.
1989: J Ramis; Ignasi Gich; J Torrent; R Mis; Francesc Jané; J Forn
Bioavailability study of fosfosal and codeine administered alone or in combination.
International journal of clinical pharmacology, therapy, and toxicology 1989;27(7):352-7.
1989: Miguel Casas; S Ferré; Josep Cadafalch; J M Grau; Francesc Jané
Rotational behaviour induced by theophylline in 6-OHDA nigrostriatal denervated rats is dependent on the supersensitivity of striatal dopaminergic receptors.
Pharmacology, biochemistry, and behavior 1989;33(3):609-13.
1989: Miguel Casas; S Ferré; A Cobos; J M Grau; Francesc Jané
Relationship between rotational behaviour induced by apomorphine and caffeine in rats with unilateral lesion of the nigrostriatal pathway.
Neuropharmacology 1989;28(4):407-9.
1989: J Torrent; I Izquierdo; R Cabezas; Francesc Jané
Theophylline-isoniazid interaction.
DICP : the annals of pharmacotherapy 1989;23(2):143-5.
1988: J Torrent; Manel J Barbanoj; V De la Fuente; Francesc Jané
Lack of antihistamine properties of single dose cinnarizine in man.
Methods and findings in experimental and clinical pharmacology 1988;10(10):663-6.
1988: Miguel Casas; S Ferré; A Cobos; Josep Cadafalch; J M Grau; Francesc Jané
Comparison between apomorphine and amphetamine-induced rotational behaviour in rats with a unilateral nigrostriatal pathway lesion.
Neuropharmacology 1988;27(6):657-9.
1988: J Torrent; I Izquierdo; Manel J Barbanoj; J Moreno; J Lauroba; Francesc Jané
UV-induced erythema model: a tool in dermatopharmacology for testing the topical activity of non-steroidal anti-inflammatory agents in man.
Methods and findings in experimental and clinical pharmacology 1988;10(5):341-5.
1988: I Izquierdo; J Torrent; A Cisteró; Francesc Jané
[How can we optimize therapy with sustained-release theophyllines?].
Medicina clínica 1988;90(17):715.
1988: Rosendo Obach; J Borja; J Pruñonosa; J M Vallès; J Torrent; I Izquierdo; Francesc Jané
Lack of correlation between lithium pharmacokinetic parameters obtained from plasma and saliva.
Therapeutic drug monitoring 1988;10(3):265-8.
1987: J Nadal; V De la Fuente; M Abadias; J Torrent; Francesc Jané
Toxic coma induced by anticholinergic eye drops.
British medical journal (Clinical research ed.) 1987;295(6609):1352.
1987: Antoni Bayés de Luna; Josep Guindo; P Torner; J Borja; M C Caturla; S García; J M Dominguez; R Oter; Francesc Jané
Value of effort testing and acute drug testing in the evaluation of antiarrhythmic treatment.
European heart journal 1987;8 Suppl A():77-82.
1986: Josep Guindo; A Rodriguez de la Serna; J Borja; R Oter; Francesc Jané; Antoni Bayés de Luna
Propafenone and a syndrome of the lupus erythematosus type.
Annals of internal medicine 1986;104(4):589.
1986: I Izquierdo; J Torrent; A Cisteró; Francesc Jané
[Non-lineal kinetic behavior of theophylline. Apropos of a case].
Medicina clínica 1986;86(4):177.
1986: Miguel Casas; Enric Alvarez; P Duro; C Garcia-Ribera; C Udina; A Velat; D Abella; J Rodriguez-Espinosa; P Salva; Francesc Jané
Antiandrogenic treatment of obsessive-compulsive neurosis.
Acta psychiatrica Scandinavica 1986;73(2):221-2.
1984: A Badía; P Bermejo; Francesc Jané
Beta-adrenergic blocking effects and cardiodepressant activity of penbutolol and its two optical isomers in the guinea-pig left atrium.
Methods and findings in experimental and clinical pharmacology 1984;6(8):445-8.
1982: Elisabet Vila; Albert Badia; Francesc Jané
A preferential blocking effect of oxprenolol on alpha 1-adrenoceptors in the rat.
The Journal of pharmacy and pharmacology 1982;34(10):671-3.
1982: Albert Badia; P Bermejo; Francesc Jané
Pre- and postsynaptic effects of sulpiride in the rat isolated vas deferens.
The Journal of pharmacy and pharmacology 1982;34(4):266-8.